Harbour BioMed & Evinova Team Up, Cornerstone Robotics Secures $200M - Life AI Weekly #42

Hi there,

In this edition of Life AI Weekly, we delve into the latest advancements in healthcare and life sciences AI. Harbour BioMed and Evinova have teamed up to enhance biologics development using AI, aiming to streamline the drug discovery process. Meanwhile, the Critical Path Institute has launched an AI coalition focused on pediatric IBD drug development, highlighting the growing role of AI in addressing complex medical challenges.

On the business front, Cornerstone Robotics has secured $200 million to expand its operations, emphasizing the increasing investment in AI-driven healthcare solutions. Additionally, Tala Health has raised $100 million to further integrate AI into healthcare, showcasing the sector's commitment to innovation. Stay tuned as we explore these stories and more, shedding light on how AI continues to transform the healthcare landscape.

Cornerstone Robotics has secured $200 million to expand its robotic surgical systems for minimally invasive procedures in hospitals across mainland China. Meanwhile, Expanse Medical is expanding to Providence, Rhode Island, with a new facility focused on AI-driven men's health innovations through Valorian Medical Technologies.

Harbour BioMed and Evinova have partnered to enhance biologics development using AI and digital technologies, aiming to improve drug development efficiency and foster an open R&D ecosystem. Meanwhile, the Critical Path Institute has launched the Critical Path Disease Modeling Coalition in Amsterdam to develop models for pediatric inflammatory bowel disease, targeting conditions like Crohn's disease and ulcerative colitis.

Harbour BioMed and Evinova have partnered to leverage AI in biologics, aiming to enhance drug discovery and development. Meanwhile, the Critical Path Institute has launched an AI coalition focused on advancing pediatric IBD drug development, highlighting the growing role of AI in medical research.

Anthill launched Anthill Cloud™, an AI platform for Pharma marketing, on November 3, 2025. EXoPERT joined JLABS TMC in Johnson & Johnson's incubator to advance AI-powered cancer diagnostics. The RNA Horizons 2025 Symposium in Palermo highlighted advances in RNA therapeutics and AI applications.

ACTO launched the ACTOverse Marketplace at the Veeva Commercial Summit in Europe, offering a digital platform to integrate content, data, and service solutions for biopharmaceutical and medical device companies. Meanwhile, Akkodis unveiled AI-driven solutions across various industries, including life sciences and IT operations, showcasing projects that enhance efficiency and workforce transformation.